National Guideline Clearinghouse | Abatacept for treating rheumatoid arthritis after the failure of conventional disease-modifying anti-rheumatic drugs (rapid review of technology appraisal guidance 234).

full-text ►
National Guideline Clearinghouse | Abatacept for treating rheumatoid arthritis after the failure of conventional disease-modifying anti-rheumatic drugs (rapid review of technology appraisal guidance 234).

National Institute for Health and Care Excellence (NICE)

October 21, 2013

Guideline Title

Abatacept for treating rheumatoid arthritis after the failure of conventional disease-modifying anti-rheumatic drugs (rapid review of technology appraisal guidance 234).

 

Bibliographic Source(s)

National Institute for Health and Care Excellence (NICE). Abatacept for treating rheumatoid arthritis after the failure of conventional disease-modifying anti-rheumatic drugs (rapid review of technology appraisal guidance 234). London (UK): National Institute for Health and Care Excellence (NICE); 2013 Apr. 46 p. (Technology appraisal guidance; no. 280).

 

Guideline Status

This is the current release of the guideline.